Although total α-synuclein in the blood has several sources, the distribution of α-synuclein in the blood may provide a window into the α-synuclein in the brain of patients with neurodegenerative diseases and reflect changes in the degree of pathology [47]. This evidence concerns the gene SNCA and neurodegenerative disease.